Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial

IMPORTANCE: The natural history of patients with newly diagnosed high-risk nonmetastatic (M0) prostate cancer receiving hormone therapy (HT) either alone or with standard-of-care radiotherapy (RT) is not well documented. Furthermore, no clinical trial has assessed the role of RT in patients with nod...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:JAMA Oncol
Κύριοι συγγραφείς: James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., Mason, Malcolm D., Parker, Christopher C., Ritchie, Alastair W. S., Russell, J. Martin, Schiavone, Francesca, Attard, Gerhardt, de Bono, Johann S., Birtle, Alison, Engeler, Daniel S., Elliott, Tony, Matheson, David, O’Sullivan, Joe, Pudney, Delia, Srihari, Narayanan, Wallace, Jan, Barber, Jim, Syndikus, Isabel, Parmar, Mahesh K. B., Sydes, Matthew R.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2016
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4789485/
https://ncbi.nlm.nih.gov/pubmed/26606329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.4350
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια